AU2019903152A0 - Targeted Dendrimer Conjugates - Google Patents
Targeted Dendrimer ConjugatesInfo
- Publication number
- AU2019903152A0 AU2019903152A0 AU2019903152A AU2019903152A AU2019903152A0 AU 2019903152 A0 AU2019903152 A0 AU 2019903152A0 AU 2019903152 A AU2019903152 A AU 2019903152A AU 2019903152 A AU2019903152 A AU 2019903152A AU 2019903152 A0 AU2019903152 A0 AU 2019903152A0
- Authority
- AU
- Australia
- Prior art keywords
- dendrimer conjugates
- targeted dendrimer
- targeted
- conjugates
- dendrimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000412 dendrimer Substances 0.000 title 1
- 229920000736 dendritic polymer Polymers 0.000 title 1
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/AU2020/050910 WO2021035310A1 (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
AU2020338481A AU2020338481A1 (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
CN202080064953.8A CN114502201A (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
JP2022513525A JP2022547434A (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer complex |
BR112022003628A BR112022003628A2 (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
CA3149263A CA3149263A1 (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
US17/637,924 US20220288216A1 (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
KR1020227008957A KR20220052960A (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
EP20859417.6A EP4021511A4 (en) | 2019-08-28 | 2020-08-28 | Targeted dendrimer conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2019903152A0 true AU2019903152A0 (en) | 2019-09-12 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019247434A1 (en) | Camptothecin Peptide Conjugates | |
EP3873486A4 (en) | Bivalent targeted conjugates | |
EP3480211A4 (en) | Hanp-fc-containing molecular conjugate | |
EP4021511A4 (en) | Targeted dendrimer conjugates | |
EP3807644A4 (en) | Antibody-oligonucleotide conjugates | |
EP3950061A4 (en) | Antibody-pyrrolobenzodiazepine derivative conjugate | |
EP3833763A4 (en) | Modified oligonucleotides targeting snps | |
EP4045023A4 (en) | Conjugate molecules | |
EP3430060A4 (en) | Conjugates enhancing total cellular accumulation | |
EP3430033A4 (en) | Insulin-incretin conjugates | |
EP3883934A4 (en) | Therapeutic dendrimer | |
EP4031143A4 (en) | Therapeutic conjugates | |
EP3496755A4 (en) | Tgf- antagonist conjugates | |
EP3735987A4 (en) | Amanitin antibody conjugate | |
EP3570892A4 (en) | Endosomal cleavable linkers | |
EP3595670A4 (en) | Drug-polymer conjugate | |
EP3823961A4 (en) | Therapeutic dendrimer | |
EP3538098A4 (en) | Antibody-drug conjugates | |
EP3999592A4 (en) | Theranostic conjugates | |
EP4037709A4 (en) | Knottin-immunostimulant conjugates and related compositions and methods | |
EP3986882A4 (en) | Beta-lactam-cannabinoid conjugate molecules | |
EP3958888A4 (en) | Slow-release cytokine conjugates | |
EP3609527A4 (en) | Protein conjugates | |
AU2019903152A0 (en) | Targeted Dendrimer Conjugates | |
EP4034557A4 (en) | Targeted autophagy conjugates and methods |